104 related articles for article (PubMed ID: 10589282)
1. [Application of CGH to the study of non-Hodgkin's lymphomas].
Arranz E; Benítez J
Sangre (Barc); 1999 Aug; 44(4):297-300. PubMed ID: 10589282
[No Abstract] [Full Text] [Related]
2. [Cytogenetic analysis in the definition and classification of non-Hodgkin's lymphomas].
Polito P; Perin T; Cilia A; Carbone A
Pathologica; 1994 Aug; 86(4):337-49. PubMed ID: 7708433
[TBL] [Abstract][Full Text] [Related]
3. Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Wessendorf S; Lichter P; Schwänen C; Fritz B; Baudis M; Walenta K; Kloess M; Döhner H; Bentz M
Ann Hematol; 2001; 80 Suppl 3():B35-7. PubMed ID: 11757703
[No Abstract] [Full Text] [Related]
4. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
[TBL] [Abstract][Full Text] [Related]
5. Interphase FISH in chronic lymphoproliferative disorders and comparative genomic hybridisation in the study of lymphomas.
Bentz M; Stilgenbauer S; Lichter P; Döhner H
Haematologica; 1999 Jun; 84 Suppl EHA-4():102-6. PubMed ID: 10907484
[No Abstract] [Full Text] [Related]
6. Karyotyping lymph node biopsies in non-Hodgkin's lymphoma.
Ross FM; Harrison CJ
Methods Mol Med; 2005; 115():93-107. PubMed ID: 15998964
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics of indolent lymphomas.
Mrózek K; Bloomfield CD
Semin Oncol; 1993 Oct; 20(5 Suppl 5):47-57. PubMed ID: 8211207
[No Abstract] [Full Text] [Related]
8. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
Stokke T; DeAngelis P; Smedshammer L; Galteland E; Steen HB; Smeland EB; Delabie J; Holte H
Br J Cancer; 2001 Dec; 85(12):1900-13. PubMed ID: 11747333
[TBL] [Abstract][Full Text] [Related]
9. Genetic abnormalities in non-Hodgkin's lymphoma as revealed by conventional and molecular cytogenetics methods of analyses.
Jhanwar SC; Denley RC
Methods Mol Biol; 2011; 730():131-48. PubMed ID: 21431639
[TBL] [Abstract][Full Text] [Related]
10. Chromosome studies in human hematologic diseases: non-Hodgkin's lymphomas.
Slavutsky I; Labal de Vinuesa M; Estévez ME; Sen L; Dupont J; Larripa I
Haematologica; 1987; 72(1):29-37. PubMed ID: 3108092
[No Abstract] [Full Text] [Related]
11. [Comparative genomic hybridization. Methodologic features].
García JL; Gutiérrez NC; Hernández JM; Sánchez MA; González MB; Arroyo JL; San Miguel JF
Sangre (Barc); 1999 Aug; 44(4):291-6. PubMed ID: 10589281
[No Abstract] [Full Text] [Related]
12. Distinguishing between immunophenotype and genotype in non-Hodgkin's lymphomas.
Gascoyne RD
Curr Hematol Rep; 2003 Nov; 2(6):443-4. PubMed ID: 14561386
[No Abstract] [Full Text] [Related]
13. Cytogenetic evolution patterns in non-Hodgkin's lymphoma.
Johansson B; Mertens F; Mitelman F
Blood; 1995 Nov; 86(10):3905-14. PubMed ID: 7579360
[TBL] [Abstract][Full Text] [Related]
14. Update: lymphoid neoplasms--molecular characterizations of non-Hodgkin's lymphomas: impact on patient management.
Chappuis PO; Sappino AP
Semin Hematol; 1995 Jul; 32(3):237-41. PubMed ID: 7570067
[No Abstract] [Full Text] [Related]
15. Secondary genomic alterations in non-Hodgkin's lymphomas: tumor-specific profiles with impact on clinical behavior.
Beà S; Campo E
Haematologica; 2008 May; 93(5):641-5. PubMed ID: 18450732
[No Abstract] [Full Text] [Related]
16. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas.
Renedo M; Martinez-Delgado B; Arranz E; Garcia M; Urioste M; Martinez-Ramirez A; Rivas C; Cigudosa JC; Benitez I
Leukemia; 2001 Oct; 15(10):1627-32. PubMed ID: 11587222
[TBL] [Abstract][Full Text] [Related]
17. I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC).
Bayerlein K; Rith T; Verdorfer I; Liehr T; Wolff E; Girod S; Gebhart E
Anticancer Res; 2000; 20(1A):427-32. PubMed ID: 10769691
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.
Pezzolo A; Capra V; Raso A; Morandi F; Parodi F; Gambini C; Nozza P; Giangaspero F; Cama A; Pistoia V; Garrè ML
Cancer Lett; 2008 Mar; 261(2):235-43. PubMed ID: 18179864
[TBL] [Abstract][Full Text] [Related]
19. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
[TBL] [Abstract][Full Text] [Related]
20. [Chromosome aberrations in non-Hodgkin lymphoma and in Hodgkin's disease].
Schouten HC
Ned Tijdschr Geneeskd; 1992 May; 136(19):913-7. PubMed ID: 1594065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
